Article Information
- Received May 13, 1997
- Revision received September 16, 1997
- Accepted September 18, 1997
- First published December 1, 1997.
- Version of record published December 1, 1997.
Author Information
- Jorge L. González1,
- Christopher J. Russo1,
- Dan Goldowitz2,
- Hope O. Sweet3,
- Muriel T. Davisson3, and
- Christopher A. Walsh1
- 1Division of Neurogenetics, Department of Neurology, Beth Israel Deaconess Medical Center, and Program in Neuroscience, Harvard Medical School, Boston, Massachusetts 02115,
- 2Department of Anatomy and Neurobiology, University of Tennessee, Memphis, Tennessee 38163, and
- 3The Jackson Laboratory, Bar Harbor, Maine 04609
Author contributions
Disclosures
- Received May 13, 1997.
- Revision received September 16, 1997.
- Accepted September 18, 1997.
J.L.G. was supported by a Ford Foundation fellowship. C.A.W. was supported by grants from the Klingenstein Foundation Fund, National Institutes of Health (NIH) Grants KO8-NS01520 and RO1-NS 32457, and the Mental Retardation Research Center Grant (NIH-P30-HD18655). C.A.W. is a Scholar of the Rita Allen Foundation. D.G. was supported by NIH Grant NS23475 and the University of Tennessee. M.T.D. and H.O.S. were supported by National Science Foundation Grant DBI 9502221 and NIH-National Center for Research Resources Grant RR01183. We thank M. Ogawa for the gift of CR-50 antiserum, R. Bronson for advice, K. Hunter for communicating data before publication, K. Allen for help with the mouse colony, and L. Garcia for assistance with histology.
Correspondence should be addressed to Dr. C. A. Walsh, Division of Neurogenetics, Beth Israel Deaconess Medical Center/Harvard Medical School, Harvard Institutes of Medicine, 77 Avenue Louis Pasteur, Boston, MA 02115.
